Recruiting
Phase 1

AMT-116 in Patients With Advanced Solid Tumors

Sponsor:

Multitude Therapeutics Inc.

Code:

NCT05725291

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AMT-116

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information